Singapore markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.0880-0.0120 (-0.39%)
As of 10:36AM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2020
30/09/2019
30/09/2018
Total revenue
0
0
0
0
Operating expenses
Research development
13,172
6,946
17,241
4,319
Selling general and administrative
11,332
10,123
9,096
3,634
Total operating expenses
24,504
17,069
26,336
9,078
Operating income or loss
-24,504
-17,069
-26,336
-9,078
Interest expense
23.731
7.686
128.951
-
Total other income/expenses net
1,565
-307.528
-492.889
-4,233
Income before tax
-22,952
-17,385
-26,958
-13,237
Income from continuing operations
-22,952
-17,385
-26,958
-13,237
Net income
-22,952
-17,385
-26,958
-13,237
Net income available to common shareholders
-22,952
-17,385
-26,958
-13,237
Basic EPS
-
-0.89
-3.26
-4.60
Diluted EPS
-
-0.89
-3.26
-4.60
Basic average shares
-
19,620
8,272
2,820
Diluted average shares
-
19,620
8,272
2,820
EBITDA
-
-17,096
-26,701
-7,954